Immunology of age-related macular degeneration (original) (raw)

• The Global Economic Cost of Visual Impairment. AMD Alliance International [online], http://www.icoph.org/resources/146/The-Global-Economic-Cost-of-Visual-Impairment.html (2010).
• Haines, J. L. et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419–421 (2005).
  Article CAS PubMed Google Scholar
• Edwards, A. O. et al. Complement factor H polymorphism and age-related macular degeneration. Science 308, 421–424 (2005).
  Article CAS PubMed Google Scholar
• Klein, R. J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385–389 (2005). References 2–4 are landmark studies showing increased statistical risk of AMD in individuals who have a single CFH polymorphism; these studies were the first of their kind for a complex human disease.
  Article CAS PubMed PubMed Central Google Scholar
• Hageman, G. S. et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA 102, 7227–7232 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Tuo, J., Grob, S., Zhang, K. & Chan, C. C. Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul. Immunol. Inflamm. 20, 27–36 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Richards, A., Kavanagh, D. & Atkinson, J. P. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration. Adv. Immunol. 96, 141–177 (2007).
  Article CAS PubMed Google Scholar
• Khandhadia, S., Cipriani, V., Yates, J. R. & Lotery, A. J. Age-related macular degeneration and the complement system. Immunobiology 217, 127–146 (2012).
  Article CAS PubMed Google Scholar
• Anderson, D. H. et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 29, 95–112 (2010). References 6–9 provide a comprehensive review and analysis of the role of the complement system in AMD.
  Article CAS PubMed Google Scholar
• Saint-Geniez, M. et al. Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS ONE 3, e3554 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bill, A., Sperber, G. & Ujiie, K. Physiology of the choroidal vascular bed. Int. Ophthalmol. 6, 101–107 (1983).
  Article CAS PubMed Google Scholar
• Hageman, G. S. et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE — Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20, 705–732 (2001).
  Article CAS PubMed Google Scholar
• Friedman, D. S. et al. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122, 564–572 (2004).
  Article PubMed Google Scholar
• Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419–1431 (2006).
  Article CAS Google Scholar
• Brown, D. M. et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1432–1444 (2006). References 14 and 15 report Phase III clinical trials showing the efficacy of VEGFA-targeted antibody therapy for neovascular AMD, which is the standard of care for this disease.
  Article CAS PubMed Google Scholar
• Bird, A. C. Therapeutic targets in age-related macular disease. J. Clin. Invest. 120, 3033–3041 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Sunness, J. S. et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology 106, 1768–1779 (1999).
  Article CAS PubMed Google Scholar
• Martin, D. F. et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119, 1388–1398 (2012).
  Article PubMed Google Scholar
• Marneros, A. G. et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am. J. Pathol. 167, 1451–1459 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sepp, T. et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest. Ophthalmol. Visual Sci. 47, 536–540 (2006).
  Article Google Scholar
• Sofat, R. et al. Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int. J. Epidemiol. 41, 250–262 (2012).
  Article PubMed PubMed Central Google Scholar
• Droz, I. et al. Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. Br. J. Ophthalmol. 92, 513–517 (2008).
  Article CAS PubMed Google Scholar
• Magnusson, K. P. et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med. 3, e5 (2006).
  Article CAS PubMed Google Scholar
• Cameron, D. J. et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 6, 1122–1125 (2007).
  Article CAS PubMed Google Scholar
• Sobrin, L. et al. Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology 119, 1874–1875 (2012).
  Article PubMed Google Scholar
• Young, R. W. Pathophysiology of age-related macular degeneration. Surv. Ophthalmol. 31, 291–306 (1987).
  Article CAS PubMed Google Scholar
• Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S. & Adamis, A. P. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48, 257–293 (2003).
  Article PubMed Google Scholar
• Sugita, S. Role of ocular pigment epithelial cells in immune privilege. Arch. Immunol. Ther. Exp. (Warsz.) 57, 263–268 (2009).
  Article Google Scholar
• Streilein, J. W. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye (Lond.) 9, 236–240 (1995).
  Article Google Scholar
• Morohoshi, K., Goodwin, A. M., Ohbayashi, M. & Ono, S. J. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J. Autoimmun. 33, 247–254 (2009).
  Article CAS PubMed Google Scholar
• Xu, H., Chen, M., Manivannan, A., Lois, N. & Forrester, J. V. Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 7, 58–68 (2008).
  Article CAS PubMed Google Scholar
• Ma, W., Zhao, L., Fontainhas, A. M., Fariss, R. N. & Wong, W. T. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS ONE 4, e7945 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, M., Forrester, J. V. & Xu, H. Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS ONE 6, e22818 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tuo, J. et al. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 48, 3827–3836 (2007).
  Article PubMed Google Scholar
• Xu, H., Chen, M. & Forrester, J. V. Para-inflammation in the aging retina. Prog. Retin. Eye Res. 28, 348–368 (2009).
  Article CAS PubMed Google Scholar
• Sakurai, E., Anand, A., Ambati, B. K., van Rooijen, N. & Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3578–3585 (2003).
  Article PubMed Google Scholar
• Espinosa-Heidmann, D. G. et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3586–3592 (2003).
  Article PubMed Google Scholar
• Shen, W. Y., Yu, M. J., Barry, C. J., Constable, I. J. & Rakoczy, P. E. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br. J. Ophthalmol. 82, 1063–1071 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Ambati, J. et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nature Med. 9, 1390–1397 (2003). CCL2- and CCR2-deficient mice were the first animal model shown to reproduce numerous features of early, intermediate and neovascular AMD. This study also directly implicates macrophage migration in retinal degeneration.
  Article CAS PubMed Google Scholar
• Combadiere, C. et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 117, 2920–2928 (2007). This study advanced the epidemiological finding that the Thr280Met CX 3 CR1 polymorphism confers AMD risk by identifying dysfunctional microglial migration in patients carrying the 280Met mutation.
  Article CAS PubMed PubMed Central Google Scholar
• Ross, R. J. et al. Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp. Res. 86, 675–683 (2008).
  CAS Google Scholar
• Luhmann, U. F. et al. The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest. Ophthalmol. Vis. Sci. 50, 5934–5943 (2009).
  Article PubMed Google Scholar
• Bruban, J. et al. CCR2/CCL2-mediated inflammation protects photoreceptor cells from amyloid-β-induced apoptosis. Neurobiol. Dis. 42, 55–72 (2011).
  Article CAS PubMed Google Scholar
• Raoul, W. et al. Lipid-bloated subretinal microglial cells are at the origin of drusen appearance in CX3CR1-deficient mice. Ophthalmic Res. 40, 115–119 (2008).
  Article CAS PubMed Google Scholar
• Tuo, J. et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J. 18, 1297–1299 (2004).
  Article CAS PubMed Google Scholar
• Chen, H., Liu, B., Lukas, T. J. & Neufeld, A. H. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS ONE 3, e2339 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Seidler, S., Zimmermann, H. W., Bartneck, M., Trautwein, C. & Tacke, F. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol. 11, 30 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, J. et al. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J. Biol. Chem. 286, 20991–21001 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Xie, P. et al. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344. PLoS ONE 6, e28933 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Raychaudhuri, S. et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nature Genet. 43, 1232–1236 (2011). The initial clear-cut description of a rare variant in CFH with high penetrance, in which the functional studies demonstrate a defect as a result of this variant. Presumably, the first of many rare variants in regulators and activators of the alternative complement pathway that predispose to AMD.
  Article CAS PubMed Google Scholar
• Anderson, D. H., Mullins, R. F., Hageman, G. S. & Johnson, L. V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134, 411–431 (2002).
  Article CAS PubMed Google Scholar
• Baudouin, C. et al. Immunohistological study of subretinal membranes in age-related macular degeneration. Jpn. J. Ophthalmol. 36, 443–451 (1992). The histological examination in this study was the first to implicate complement disturbances in AMD, preceding GWASs by 13 years.
  CAS PubMed Google Scholar
• Clark, S. J. et al. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J. Biol. Chem. 285, 30192–30202 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Sjöberg, A. P. et al. The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells. J. Biol. Chem. 282, 10894–10900 (2007).
  Article CAS PubMed Google Scholar
• Laine, M. et al. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J. Immunol. 178, 3831–3836 (2007).
  Article CAS PubMed Google Scholar
• Johnson, P. T. et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl Acad. Sci. USA 103, 17456–17461 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Hollyfield, J. G. et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nature Med. 14, 194–198 (2008).
  Article CAS PubMed Google Scholar
• Doyle, S. L. et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nature Med. 18, 791–798 (2012).
  Article CAS PubMed Google Scholar
• Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847–859 (2012). The first study to show that inflammasome activation in RPE is a crucial driver of geographic atrophy.
  Article CAS PubMed PubMed Central Google Scholar
• Kaneko, H. et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471, 325–330 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tseng, W. A. et al. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 54, 110–120 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Kauppinen, A. et al. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-Implications for age-related macular degeneration (AMD). Immunol. Lett. 147, 29–33 (2012).
  Article CAS PubMed Google Scholar
• Liu, R. T. et al. Inflammatory mediators induced by amyloid-β in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 54, 2225–2237 (2013).
  Article CAS PubMed Google Scholar
• Kleinman, M. E. et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452, 591–597 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kleinman, M. E. et al. Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol. Ther. 20, 101–108 (2012).
  Article CAS PubMed Google Scholar
• Lavalette, S. et al. Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am. J. Pathol. 178, 2416–2423 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kumar, M. V., Nagineni, C. N., Chin, M. S., Hooks, J. J. & Detrick, B. Innate immunity in the retina: toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J. Neuroimmunol. 153, 7–15 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, Z. et al. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N. Engl. J. Med. 359, 1456–1463 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zareparsi, S. et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum. Mol. Genet. 14, 1449–1455 (2005).
  Article CAS PubMed Google Scholar
• Cho, Y. et al. Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples. Invest. Ophthalmol. Vis. Sci. 50, 5614–5618 (2009).
  Article PubMed Google Scholar
• Shiose, S. et al. Toll-like receptor 3 is required for development of retinopathy caused by impaired all-_trans_-retinal clearance in mice. J. Biol. Chem. 286, 15543–15555 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• West, X. Z. et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972–976 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fujimoto, T. et al. Choroidal neovascularization enhanced by _Chlamydia pneumonia_e via Toll-like receptor 2 in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 51, 4694–4702 (2010).
  Article PubMed Google Scholar
• Patel, N. et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 115, 422–430 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Penfold, P. L., Provis, J. M., Furby, J. H., Gatenby, P. A. & Billson, F. A. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 228, 270–274 (1990). References 57 and 75 provided the first evidence, in mice and humans, that autoantibodies are involved in AMD.
  Article CAS PubMed Google Scholar
• Cherepanoff, S., Mitchell, P., Wang, J. J. & Gillies, M. C. Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clin. Exp. Ophthalmol. 34, 590–595 (2006).
  Article PubMed Google Scholar
• Zhou, J., Jang, Y. P., Kim, S. R. & Sparrow, J. R. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc. Natl Acad. Sci. USA 103, 16182–16187 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Fernandes, A. F. et al. Oxidative inactivation of the proteasome in retinal pigment epithelial cells. A potential link between oxidative stress and up-regulation of interleukin-8. J. Biol. Chem. 283, 20745–20753 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bian, Q. et al. Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radic. Biol. Med. 53, 1298–1307 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sparrow, J. R., Zhou, J. & Cai, B. DNA is a target of the photodynamic effects elicited in A2E-laden RPE by blue-light illumination. Invest. Ophthalmol. Vis. Sci. 44, 2245–2251 (2003).
  Article PubMed Google Scholar
• Sparrow, J. R., Nakanishi, K. & Parish, C. A. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci. 41, 1981–1989 (2000).
  CAS PubMed Google Scholar
• Radu, R. A. et al. Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration. J. Biol. Chem. 286, 18593–18601 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Iriyama, A. et al. A2E, a component of lipofuscin, is pro-angiogenic in vivo. J. Cell. Physiol. 220, 469–475 (2009).
  Article CAS PubMed Google Scholar
• Catala, A. Lipid peroxidation of membrane phospholipids in the vertebrate retina. Front. Biosci. (Schol Ed) 3, 52–60 (2011).
  Article Google Scholar
• Hoppe, G., O'Neil, J., Hoff, H. F. & Sears, J. Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium. Biochim. Biophys. Acta 1689, 33–41 (2004).
  Article CAS PubMed Google Scholar
• Krohne, T. U., Stratmann, N. K., Kopitz, J. & Holz, F. G. Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp. Res. 90, 465–471 (2010).
  CAS Google Scholar
• Weismann, D. et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478, 76–81 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sharma, A. et al. 4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells. Arch. Biochem. Biophys. 480, 85–94 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dentchev, T., Milam, A. H., Lee, V. M., Trojanowski, J. Q. & Dunaief, J. L. Amyloid-β is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol. Vision 9, 184–190 (2003).
  CAS Google Scholar
• Ding, J. D. et al. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc. Natl Acad. Sci. USA 108, e279–e287 (2011).
  Article PubMed PubMed Central Google Scholar
• Liu, X. C., Liu, X. F., Jian, C. X., Li, C. J. & He, S. Z. IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells. Inflammation 35, 776–784 (2012).
  Article CAS PubMed Google Scholar
• Ambati, J. & Fowler, B. J. Mechanisms of age-related macular degeneration. Neuron 75, 26–39 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Killingsworth, M. C., Sarks, J. P. & Sarks, S. H. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (Lond.) 4, 613–621 (1990).
  Article Google Scholar
• Lopez, P. F. et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am. J. Ophthalmol. 112, 647–656 (1991).
  Article CAS PubMed Google Scholar
• Oh, H. et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 40, 1891–1898 (1999).
  CAS PubMed Google Scholar
• Seregard, S., Algvere, P. V. & Berglin, L. Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefes Arch. Clin. Exp. Ophthalmol. 232, 325–329 (1994).
  Article CAS PubMed Google Scholar
• Tsutsumi-Miyahara, C. et al. The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation. Br. J. Ophthalmol. 88, 1217–1222 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Cherepanoff, S., McMenamin, P., Gillies, M. C., Kettle, E. & Sarks, S. H. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br. J. Ophthalmol. 94, 918–925 (2010).
  Article CAS PubMed Google Scholar
• Grossniklaus, H. E. et al. Correlation of histologic 2-dimensional reconstruction and confocal scanning laser microscopic imaging of choroidal neovascularization in eyes with age-related maculopathy. Arch. Ophthalmol. 118, 625–629 (2000).
  Article CAS PubMed Google Scholar
• Apte, R. S., Richter, J., Herndon, J. & Ferguson, T. A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med. 3, e310 (2006). References 36, 37, 99 and 100 show the diverging roles of macrophages in neovascular AMD.
  Article CAS PubMed PubMed Central Google Scholar
• Cao, X. et al. Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol. Int. 61, 528–535 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hasegawa, E. et al. IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn. J. Leukoc. Biol. 91, 267–273 (2012).
  Article CAS PubMed Google Scholar
• Matsumura, N. et al. Low-dose lipopolysaccharide pretreatment suppresses choroidal neovascularization via IL-10 induction. PLoS ONE 7, e39890 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kelly, J., Ali Khan, A., Yin, J., Ferguson, T. A. & Apte, R. S. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J. Clin. Invest. 117, 3421–3426 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, J. et al. Neutrophils promote experimental choroidal neovascularization. Mol. Vision 11, 414–424 (2005).
  CAS Google Scholar
• Zhou, J. et al. Neutrophils compromise retinal pigment epithelial barrier integrity. J. Biomed. Biotechnol. 2010, 289360 (2010).
  PubMed PubMed Central Google Scholar
• Penfold, P. L., Provis, J. M. & Billson, F. A. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch. Clin. Exp. Ophthalmol. 225, 70–76 (1987).
  Article CAS PubMed Google Scholar
• Luo, L. et al. Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. ACS Nano. 7, 3264–3275 (2013)
  Article CAS PubMed PubMed Central Google Scholar
• Martin, D. F. et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 364, 1897–1908 (2011).
  Article CAS PubMed Google Scholar
• Jonas, J. B., Degenring, R. F., Kreissig, I., Friedemann, T. & Akkoyun, I. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye (Lond.) 19, 163–170 (2005).
  Article CAS Google Scholar
• Gillies, M. C. et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch. Ophthalmol. 121, 667–673 (2003).
  Article CAS PubMed Google Scholar
• Smailhodzic, D. et al. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration. Ophthalmology 119, 2304–2311 (2012).
  Article PubMed Google Scholar
• Hagstrom, S. A. et al. Pharmacogenetics for genes associated with age-related macular degeneration (AMD) in the comparison of AMD treatments trials (CATT). Ophthalmology 120, 593–599 (2013).
  Article PubMed Google Scholar
• Scholl, H. P. et al. CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS ONE 4, e7418 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Klein, M. L. et al. Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology 117, 1554–1559.e1 (2010).
  Article PubMed Google Scholar
• Nozaki, M. et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl Acad. Sci. USA 103, 2328–2333 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Curcio, C. A. et al. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, yopography, and biogenesis model. Retina 33, 265–276 (2013).
  Article PubMed Google Scholar
• Johnson, L. V. et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc. Natl Acad. Sci. USA 108, 18277–18282 (2011).
  Article PubMed PubMed Central Google Scholar
• Wang, A. L. et al. Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS ONE 4, e4160 (2009).
  Article PubMed PubMed Central Google Scholar
• Munch, I. C. et al. Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye Study. Invest. Ophthalmol. Vis. Sci. 51, 2317–2321 (2010).
  Article PubMed Google Scholar
• Seddon, J. M., Reynolds, R. & Rosner, B. Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies. Invest. Ophthalmol. Vis. Sci. 50, 586–591 (2009).
  Article PubMed PubMed Central Google Scholar
• Hageman, G. S. & Mullins, R. F. Molecular composition of drusen as related to substructural phenotype. Mol. Vis. 5, 28 (1999).
  CAS PubMed Google Scholar
• Crabb, J. W. et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA 99, 14682–14687 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hollyfield, J. G., Salomon, R. G. & Crabb, J. W. Proteomic approaches to understanding age-related macular degeneration. Adv. Exp. Med. Biol. 533, 83–89 (2003).
  Article CAS PubMed Google Scholar
• Johnson, L. V. et al. The Alzheimer's Aβ -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl Acad. Sci. USA 99, 11830–11835 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Klein, M. L. et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 115, 1026–1031 (2008).
  Article PubMed Google Scholar
• Friese, M. A. et al. FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol. Immunol. 36, 809–818 (1999).
  Article CAS PubMed Google Scholar
• Spencer, K. L. et al. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum. Mol. Genet. 17, 971–977 (2008).
  Article CAS PubMed Google Scholar
• Heurich, M. et al. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc. Natl Acad. Sci. USA 108, 8761–8766 (2011).
  Article PubMed PubMed Central Google Scholar
• Takeda, A. et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460, 225–230 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, H. et al. Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling. Invest. Ophthalmol. Vis. Sci. 52, 8271–8277 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mo, F. M., Proia, A. D., Johnson, W. H., Cyr, D. & Lashkari, K. Interferon γ-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 51, 4226–4236 (2010).
  Article PubMed Google Scholar
• Sharma, N. K. et al. New biomarker for neovascular age-related macular degeneration: eotaxin-2. DNA Cell Biol. 31, 1618–1627 (2012).
  Article CAS PubMed Google Scholar
• Mizutani, T., Ashikari, M., Tokoro, M., Nozaki, M. & Ogura, Y. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist. Invest. Ophthalmol. Vis. Sci. 54, 1564–1572 (2013).
  Article CAS PubMed Google Scholar
• Seddon, J. M., George, S., Rosner, B. & Rifai, N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch. Ophthalmol. 123, 774–782 (2005).
  Article PubMed Google Scholar
• Dankbar, B. et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 95, 2630–2636 (2000).
  CAS PubMed Google Scholar
• Izumi-Nagai, K. et al. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am. J. Pathol. 170, 2149–2158 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Leung, K. W., Barnstable, C. J. & Tombran-Tink, J. Bacterial endotoxin activates retinal pigment epithelial cells and induces their degeneration through IL-6 and IL-8 autocrine signaling. Mol. Immunol. 46, 1374–1386 (2009).
  Article CAS PubMed Google Scholar
• Fujimura, S. et al. Angiostatic effect of CXCR3 expressed on choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 53, 1999–2006 (2012).
  Article CAS PubMed Google Scholar
• Arakawa, S. et al. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nature Genet. 43, 1001–1004 (2011).
  Article CAS PubMed Google Scholar
• Nakata, I. et al. Association of genetic variants on 8p21 and 4q12 with age-related macular degeneration in Asian populations. Invest. Ophthalmol. Vis. Sci. 53, 6576–6581 (2012).
  Article CAS PubMed Google Scholar
• Lichtlen, P., Lam, T. T., Nork, T. M., Streit, T. & Urech, D. M. Relative contribution of VEGF and TNF-α in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105. Invest. Ophthalmol. Vis. Sci. 51, 4738–4745 (2010).
  Article PubMed Google Scholar
• Olson, J. L., Courtney, R. J. & Mandava, N. Intravitreal infliximab and choroidal neovascularization in an animal model. Arch. Ophthalmol. 125, 1221–1224 (2007).
  Article CAS PubMed Google Scholar
• Shi, X. et al. Inhibition of TNF-α reduces laser-induced choroidal neovascularization. Exp. Res. 83, 1325–1334 (2006).
  CAS Google Scholar
• de Oliveira Dias, J. R. et al. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy. Br. J. Ophthalmol. 95, 1631–1637 (2011).
  Article PubMed Google Scholar
• Sengupta, N. et al. Preventing stem cell incorporation into choroidal neovascularization by targeting homing and attachment factors. Invest. Ophthalmol. Vis. Sci. 46, 343–348 (2005).
  Article PubMed Google Scholar
• Lee, E. & Rewolinski, D. Evaluation of CXCR4 inhibition in the prevention and intervention model of laser-induced choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 51, 3666–3672 (2010).
  Article PubMed Google Scholar
• Guerin, E. et al. SDF1-α is associated with VEGFR-2 in human choroidal neovascularisation. Microvasc. Res. 75, 302–307 (2008).
  Article CAS PubMed Google Scholar
• Bhutto, I. A., McLeod, D. S., Merges, C., Hasegawa, T. & Lutty, G. A. Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration. Br. J. Ophthalmol. 90, 906–910 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Mevorach, D. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Apoptosis 15, 1114–1123 (2010).
  Article CAS PubMed Google Scholar
• Wang, Q. et al. Identification of a central role for complement in osteoarthritis. Nature Med. 17, 1674–1679 (2011).
  Article CAS PubMed Google Scholar
• Wu, G. et al. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex. Circ. Res. 104, 550–558 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Szeplaki, G., Varga, L., Fust, G. & Prohaszka, Z. Role of complement in the pathomechanism of atherosclerotic vascular diseases. Mol. Immunol. 46, 2784–2793 (2009).
  Article CAS PubMed Google Scholar
• Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nature Immunol. 12, 204–212 (2011).
  Article CAS Google Scholar
• Fritsche, L. G. et al. Seven new loci associated with age-related macular degeneration. Nature Genet. 45, 433–439 (2013).
  Article CAS PubMed Google Scholar
• Landa, G., Butovsky, O., Shoshani, J., Schwartz, M. & Pollack, A. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr. Res. 33, 1011–1013 (2008).
  CAS Google Scholar
• Nussenblatt, R. B. et al. A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization. Retina 30, 1579–1587 (2010).
  Article PubMed PubMed Central Google Scholar
• Gomi, F., Sawa, M., Tsujikawa, M. & Nishida, K. Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration. Retina 32, 1804–1810 (2012).
  Article CAS PubMed Google Scholar
• Ahmadieh, H. et al. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial. Retina 31, 1819–1826 (2011).
  Article CAS PubMed Google Scholar
• Lachmann, P. J. The amplification loop of the complement pathways. Adv. Immunol. 104, 115–149 (2009).
  Article CAS PubMed Google Scholar